arrow_back Back Filing freshness 10-K FY 2026 SEC EDGAR

NATURAL ALTERNATIVES INTERNATIONAL INC

NAII
$1.12 ▲ +0.05 (+4.67%) at close
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
17 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
20
Health
Poor
Bearish
auto_awesome

Analytical Summary

NATURAL ALTERNATIVES INTERNATIONAL INC faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $6.8M
Dividend Yield —
Revenue Growth 9.7% ↘
Op. Margin -13.2% ↘
ROIC -38.3% ↘
FCF / Share $-2.09 ↘
Trailing P/E —
Price / Book 0.1x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$142.51M
↑ +9.7% —
Net Income Profit after all expenses
$-20.70M
↓ -52.4% —
Operating Margin Operating profit as % of sales
-13.2%
↓ -97.3% 9th
FCF / Share Free cash flow per share
$-2.09
↓ -637.0% —
Long-Term Debt Long-term obligations
$0.00
— —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability →
8
Returns
17
Financial Health
27
Cash Quality
43

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 17 years · 65 quarters